106 related articles for article (PubMed ID: 24051972)
1. Clinical effects of diet supplementation with DHA in pediatric patients suffering from cystic fibrosis.
Leggieri E; De Biase RV; Savi D; Zullo S; Halili I; Quattrucci S
Minerva Pediatr; 2013 Aug; 65(4):389-98. PubMed ID: 24051972
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
3. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
[TBL] [Abstract][Full Text] [Related]
4. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis.
Alicandro G; Faelli N; Gagliardini R; Santini B; Magazzù G; Biffi A; Risé P; Galli C; Tirelli AS; Loi S; Valmarana L; Cirilli N; Palmas T; Vieni G; Bianchi ML; Agostoni C; Colombo C
Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):163-9. PubMed ID: 23266209
[TBL] [Abstract][Full Text] [Related]
8. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
López-Neyra A; Suárez L; Muñoz M; de Blas A; Ruiz de Valbuena M; Garriga M; Calvo J; Ribes C; Girón Moreno R; Máiz L; González D; Bousoño C; Manzanares J; Pastor Ó; Martínez-Botas J; Del Campo R; Cantón R; Roy G; Menacho M; Arroyo D; Zamora J; Soriano JB; Lamas A
Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102186. PubMed ID: 33038833
[TBL] [Abstract][Full Text] [Related]
9. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
11. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.
Morin C; Cantin AM; Vézina FA; Fortin S
Mar Drugs; 2018 May; 16(6):. PubMed ID: 29861448
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography/electrospray ionization ion-trap tandem mass spectrometric analysis and quantification of phosphatidylcholine molecular species in the serum of cystic fibrosis subjects supplemented with docosahexaenoic acid.
Pacetti D; Malavolta M; Bocci F; Boselli E; Frega NG
Rapid Commun Mass Spectrom; 2004; 18(20):2395-400. PubMed ID: 15386630
[TBL] [Abstract][Full Text] [Related]
16. Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.
Ayats-Vidal R; Bosque-García M; Cordobilla B; Asensio-De la Cruz O; García-González M; Loureda-Pérez S; Fernández-López E; Robert-Barriocanal E; Valiente-Planas A; Domingo JC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613004
[TBL] [Abstract][Full Text] [Related]
17. Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice.
Weise C; Heunemann C; Loddenkemper C; Herz U; van Tol EA; Worm M
Pediatr Allergy Immunol; 2011 Aug; 22(5):497-504. PubMed ID: 21294775
[TBL] [Abstract][Full Text] [Related]
18. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
[TBL] [Abstract][Full Text] [Related]
19. Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function.
Gorjão R; Verlengia R; Lima TM; Soriano FG; Boaventura MF; Kanunfre CC; Peres CM; Sampaio SC; Otton R; Folador A; Martins EF; Curi TC; Portiolli EP; Newsholme P; Curi R
Clin Nutr; 2006 Dec; 25(6):923-38. PubMed ID: 16697494
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation with pressurized whey in patients with cystic fibrosis.
Lands LC; Iskandar M; Beaudoin N; Meehan B; Dauletbaev N; Berthiuame Y
J Med Food; 2010 Feb; 13(1):77-82. PubMed ID: 20136439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
